Recent animal studies have revealed STING (Stimulator of interferon genes) as a potential key player in Alzheimer's disease (AD). The actual impact of human STING on AD, however, is unknown. Mouse STING studies were done in WT/WT. However, TMEM173, the human gene encodes STING, has 5 common, distinct, sometimes opposite functional alleles that result in 25 TMEM173 genotypes. Only ∼50% of whites, 36% of African Americans (AA), 22% of East Asians are WT/WT. Past STING cancer immunotherapy clinic trials, which did not consider human TMEM173 heterogeneity, all failed.
Objective
(1) Discover new protective and risk AD genetic factors across populations or AA-specific. (2) Establish the physiological significance of common human TMEM173 genotypes and human diseases.
Methods
We conduct a large-scale (∼15,000 individuals) case-control analysis between TMEM173 genotypes and AD using data from The National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site. The data include late-onset AD (LOAD) non-Hispanic White (NHW), early-onset AD (EOAD) NHW, and AA.
Results
A common H232/HAQ TMEM173 genotype is associated with AD protection across the populations. An AA-specific TMEM173 genotype H232/Q293 increases the risk for AA males (OR = 17.7148), especially in the APOE ε3/ε3 population.
Conclusions
The findings discovered the first AA-specific high AD risk factor and established an association between human TMEM173 and AD, paving the way for STING-targeting effective AD healthcare.
KarchCMGoateAM. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry2015; 77: 43–51.
3.
EfthymiouAGGoateAM. Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk. Mol Neurodegener2017; 12: 43.
4.
Podlesny-DrabiniokAMarcoraEGoateAM. Microglial phagocytosis: a disease-associated process emerging from Alzheimer's disease genetics. Trends Neurosci2020; 43: 965–979.
5.
HeSLiXMittraN, et al.Microglial cGAS deletion preserves intercellular communication and alleviates amyloid-beta-induced pathogenesis of Alzheimer's disease. Adv Sci (Weinh)2025; 12: e2410910.
6.
GovindarajuluMRameshSBeasleyM, et al.Role of cGAS-sting signaling in Alzheimer's disease. Int J Mol Sci2023; 24: 8151.
7.
WeiFLWangTFWangCL, et al.Cytoplasmic escape of mitochondrial DNA mediated by Mfn2 downregulation promotes microglial activation via cGas-sting axis in spinal cord injury. Adv Sci (Weinh)2024; 11: e2305442.
8.
ThanosJMCampbellOCCowanMN, et al.STING Deletion protects against amyloid beta-induced Alzheimer's disease pathogenesis. Alzheimers Dement2025; 21: e70305.
9.
YangKTangZXingC, et al.STING Signaling in the brain: molecular threats, signaling activities, and therapeutic challenges. Neuron2024; 112: 539–557.
10.
PaulBDSnyderSHBohrVA. Signaling by cGAS-STING in neurodegeneration, neuroinflammation, and aging. Trends Neurosci2021; 44: 83–96.
11.
FryerALAbdullahATaylorJM, et al.The complexity of the cGAS-STING pathway in CNS pathologies. Front Neurosci2021; 15: 621501.
12.
XieXMaGLiX, et al.Activation of innate immune cGAS-STING pathway contributes to Alzheimer's pathogenesis in 5xFAD mice. Nat Aging2023; 3: 202–212.
13.
GulenMFSamsonNKellerA, et al.cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature2023; 620: 374–380.
14.
ChungSJeongJHParkJC, et al.Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer's disease pathologies. Exp Mol Med2024; 56: 1936–1951.
15.
FialaMHammockBDHwangSH, et al.Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-beta clearance underlying vascular complications of Alzheimer's disease. J Alzheimers Dis2025; 104: 150–157.
16.
SienskiGNarayanPBonnerJM, et al.APOE4 Disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci Transl Med2021; 13: eaaz4564.
17.
MahleyRWWeisgraberKHHuangY. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A2006; 103: 5644–5651.
18.
FarrerLACupplesLAHainesJL, et al.Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA1997; 278: 1349–1356.
19.
RajabliFFelicianoBECelisK, et al.Ancestral origin of ApoE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet2018; 14: e1007791.
PatelSJinL. TMEM173 Variants and potential importance to human biology and disease. Genes Immun2019; 20: 82–89.
22.
JinLXuLGYangIV, et al.Identification and characterization of a loss-of-function human MPYS variant. Genes Immun2011; 12: 263–269.
23.
PatelSBlaauboerSMTuckerHR, et al.The common R71H-G230A-R293Q human TMEM173 is a null allele. J Immunol2017; 198: 776–787.
24.
MansouriSGogoiHPatelS, et al.MPYS Modulates fatty acid metabolism and immune tolerance at homeostasis independent of type I IFNs. J Immunol2022; 209: 2114–2132.
25.
AlbersPKMcVeanG. Dating genomic variants and shared ancestry in population-scale sequencing data. PLoS Biol2020; 18: e3000586.
26.
Aybar-TorresAASaldarriagaLAPhamAT, et al.The common Sting1 HAQ, AQ alleles rescue CD4 T cellpenia, restore T-regs, and prevent SAVI (N153S) inflammatory disease in mice. Elife2024; 13: RP96790.
27.
SebastianMHsiaoCJFutchHS, et al.Obesity and STING1 genotype associate with 23-valent pneumococcal vaccination efficacy. JCI Insight2020; 5: e136141.
28.
MallickSLiHLipsonM, et al.The simons genome diversity project: 300 genomes from 142 diverse populations. Nature2016; 538: 201–206.
29.
PaganiLLawsonDJJagodaE, et al.Genomic analyses inform on migration events during the peopling of eurasia. Nature2016; 538: 238–242.
30.
van OvenMKayserM. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat2009; 30: E386–E394.
31.
PoznikGDXueYMendezFL, et al.Punctuated bursts in human male demography inferred from 1,244 worldwide Y-chromosome sequences. Nat Genet2016; 48: 593–599.
32.
HamannLRuiz-MorenoJSSzwedM, et al.STING SNP R293Q is associated with a decreased risk of aging-related diseases. Gerontology2019; 65: 145–154.
33.
HamannLSzwedMMossakowskaM, et al.First evidence for STING SNP R293Q being protective regarding obesity-associated cardiovascular disease in age-advanced subjects - a cohort study. Immun Ageing2020; 17: 7.
34.
AltmanDG. Practical statistics for medical research. New York: Chapman and Hall/CRC, 1990.
35.
SheskinDJ. Handbook of parametric and nonparametric statistical procedures, Fifth Edition. New York: Chapman and Hall/CRC, 2011.
36.
BaiJLiuF. cGAS‒STING signaling and function in metabolism and kidney diseases. J Mol Cell Biol2021; 13: 728–738.
37.
ChenCYangRXXuHG. STING And liver disease. J Gastroenterol2021; 56: 704–712.
38.
AnCLiZChenY, et al.The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives. Cell Biosci2024; 14: 58.
39.
SamsonNAblasserA. The cGAS-STING pathway and cancer. Nat Cancer2022; 3: 1452–1463.
40.
ZhangZWangXZhaoC, et al.STING And metabolism-related diseases: roles, mechanisms, and applications. Cell Signal2025; 132: 111833.
41.
PhamATOliveiraACAlbannaM, et al.Non-interferon-dependent role of STING signaling in pulmonary hypertension. Arterioscler Thromb Vasc Biol2024; 44: 124–142.
42.
HuYChenBYangF, et al.Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: biologic function, mechanisms and clinical prospection. Autoimmun Rev2022; 21: 103155.
43.
HouYWeiYLautrupS, et al.NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING. Proc Natl Acad Sci U S A2021; 118: e2011226118.
44.
HydeVRZhouCFernandezJR, et al.Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer's disease. Cell Rep2025; 44: 115109.
45.
TianLLongGZhuS, et al.Nanoimmunomodulation of the abeta-STING feedback machinery in microglia for Alzheimer's disease treatment. Proc Natl Acad Sci U S A2025; 122: e2427257122.
46.
SzegoEMMalzLBernhardtN, et al.Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice. Elife2022; 11: e81943.
47.
GaidtMMEbertTSChauhanD, et al.The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell2017; 171: 1110–1124 e1118.
48.
KuhlNLinderAPhilippN, et al.STING Agonism turns human T cells into interferon-producing cells but impedes their functionality. EMBO Rep2023; 24: e55536.
49.
Silveira PrudenteAHoon LeeSRohJ, et al.Microglial STING activation alleviates nerve injury-induced neuropathic pain in male but not female mice. Brain Behav Immun2024; 117: 51–65.
50.
KhedrSDissanayakeLVAlsheikhAJ, et al.Role of cGAS/STING pathway in aging and sexual dimorphism in diabetic kidney disease. JCI Insight2024; 10: e174126.
51.
LogueMWDasguptaSFarrerLA. Genetics of Alzheimer's disease in the African American population. J Clin Med2023; 12: 5189.
52.
GreenRCCupplesLAGoR, et al.Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA2002; 287: 329–336.
53.
FroehlichTEBogardusSTJr.InouyeSK. Dementia and race: are there differences between African Americans and caucasians?J Am Geriatr Soc2001; 49: 477–484.
54.
BarnesLL. Alzheimer disease in African American individuals: increased incidence or not enough data?Nat Rev Neurol2022; 18: 56–62.
55.
KunkleBWSchmidtMKleinHU, et al.Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis. JAMA Neurol2021; 78: 102–113.
56.
RoyseSKSnitzBEHillAV, et al.Apolipoprotein E and Alzheimer's disease pathology in African American older adults. Neurobiol Aging2024; 139: 11–19.
57.
Le GuenYRaulinACLogueMW, et al.Association of African ancestry-specific APOE missense variant R145C with risk of Alzheimer disease. JAMA2023; 329: 551–560.
58.
SimchoniNKoideSLikhiteM, et al.The common HAQ STING allele prevents clinical penetrance of COPA syndrome. J Exp Med2025; 222: e20242179.
59.
Ruiz-MorenoJSHamannLShahJA, et al.The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans. PLoS Pathog2018; 14: e1006829.
60.
LiuBCarlsonRJPiresIS, et al. Human STING is a proton channel. Science2023; 381: 508–514.
61.
XunJZhangZLvB, et al.A conserved ion channel function of STING mediates noncanonical autophagy and cell death. EMBO Rep2024; 25: 544–569.
62.
HinesJBKacewAJSweisRF. The development of STING agonists and emerging results as a cancer immunotherapy. Curr Oncol Rep2023; 25: 189–199.
63.
LiuYLuXQinN, et al.STING, a promising target for small molecular immune modulator: a review. Eur J Med Chem2021; 211: 113113.
64.
ZhengJMoJZhuT, et al.Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy. Mol Cancer2020; 19: 133.
65.
LaraPNJr.DouillardJYNakagawaK, et al.Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer. J Clin Oncol2011; 29: 2965–2971.
66.
Meric-BernstamFSweisRFKasperS, et al.Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study. Clin Cancer Res2023; 29: 110–121.
67.
Meric-BernstamFSweisRFHodiFS, et al.Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced/metastatic solid tumors or lymphomas. Clin Cancer Res2022; 28: 677–688.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
